{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:14:59Z","timestamp":1782814499379,"version":"3.54.5"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/md.0000000000005900","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T05:40:22Z","timestamp":1484718022000},"page":"e5900","source":"Crossref","is-referenced-by-count":11,"title":["Development of diabetes mellitus associated with quetiapine"],"prefix":"10.1097","volume":"96","author":[{"given":"Hideki","family":"Nanasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akahito","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Mitsutsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Nonogaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriyasu","family":"Uju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekatsu","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210309","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4088\/PCC.v05n0103","article-title":"Metabolic issues with atypical antipsychotics in primary care: dispelling the myths","volume":"5","author":"Kabinoff","year":"2003","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R2-23-20210309","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R3-23-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0269881105058380","article-title":"Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?","volume":"19","author":"Gough","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R4-23-20210309","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Association, American Psychiatric Association, American Association of Clinical Endocrinologists. Consensus development conference on antipsychotic drugs and obesity and diabetes.","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"R5-23-20210309","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0006-3223(98)00100-0","article-title":"Novel antipsychotics and new onset diabetes","volume":"44","author":"Wirshing","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R6-23-20210309","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1525-1497.2004.40126.x","article-title":"Weight gain and new onset diabetes associated with olanzapine and risperidone","volume":"19","author":"Farwell","year":"2004","journal-title":"J Gen Intern Med"},{"key":"R7-23-20210309","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/diacare.26.5.1597","article-title":"Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes","volume":"26","author":"Lean","year":"2003","journal-title":"Diabetes Care"},{"key":"R8-23-20210309","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","article-title":"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia","volume":"159","author":"Sernyak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R9-23-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"R10-23-20210309","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4088\/JCP.v65n0619","article-title":"A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus","volume":"65","author":"Koller","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R11-23-20210309","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.pnpbp.2006.02.007","article-title":"New-onset type-2 diabetes associated with atypical antipsychotic medications","volume":"30","author":"Lambert","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R12-23-20210309","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1176\/appi.ajp.161.9.1709","article-title":"Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications","volume":"161","author":"Leslie","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R13-23-20210309","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"R14-23-20210309","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(03)12151-4","article-title":"Obesity and type 2 diabetes in Japanese patients","volume":"361","author":"Sone","year":"2003","journal-title":"Lancet"},{"key":"R15-23-20210309","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/86.2.353","article-title":"Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT)","volume":"86","author":"Lear","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R16-23-20210309","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2003-030301","article-title":"Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States","volume":"88","author":"Chandalia","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-23-20210309","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2005-871245","article-title":"Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report","volume":"38","author":"Takahashi","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"R18-23-20210309","first-page":"519","article-title":"Quetiapine-induced ketoacidosis, a case report","volume":"51","author":"Takano","year":"2008","journal-title":"J Jpn Diabet Soc"},{"key":"R19-23-20210309","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Investig"},{"key":"R20-23-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1984.tb05013.x","article-title":"Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels","volume":"18","author":"Howarth","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"R21-23-20210309","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"R22-23-20210309","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1247\/csf.13012","article-title":"The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic \u03b2 cells by blocking PERK-mediated translational attenuation","volume":"38","author":"Ozasa","year":"2013","journal-title":"Cell Struct Funct"},{"key":"R23-23-20210309","first-page":"755","article-title":"Effect of quetiapine fumarate on blood glucose levels schizophrenic patients; A follow-up study of subjects participating in the Observational Study in general practice","volume":"21","author":"Nakamura","year":"2006","journal-title":"Jpn J Psychiat Treat"},{"key":"R24-23-20210309","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.pnpbp.2011.07.003","article-title":"Screening for diabetes using monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a 1-year follow-up study","volume":"35","author":"Kusumi","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R25-23-20210309","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.325.7358.243","article-title":"Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study","volume":"325","author":"Koro","year":"2002","journal-title":"BMJ"},{"key":"R26-23-20210309","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1192\/bjp.bp.107.037184","article-title":"First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis","volume":"192","author":"Smith","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R27-23-20210309","first-page":"1591","article-title":"The prognosis of glucose intolerance and psychiatric condition after long-term observation of the patients who developed new-onset diabetes mellitus during the second-generation antipsychotic treatment","volume":"9","author":"Murashita","year":"2006","journal-title":"Jpn J Clin psychopharmacol"},{"key":"R28-23-20210309","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3371\/CSRP.STAW.01062013","article-title":"Diabetes resolution following discontinuation of a second-generation antipsychotic","volume":"6","author":"Strassnig","year":"2013","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"R29-23-20210309","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4088\/JCP.v60n0809f","article-title":"New-onset diabetes mellitus associated with the initiation of quetiapine treatment","volume":"60","author":"Sobel","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R30-23-20210309","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1176\/appi.ajp.2008.08030383","article-title":"Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents","volume":"166","author":"Haupt","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R33-23-20210309","first-page":"681","article-title":"Screening for glucose tolerance in patients treated with atypical antipsychotics: follow-up study","volume":"54","author":"Tsubouchi","year":"2012","journal-title":"Clin Psychiatry"},{"key":"R34-23-20210309","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1440-1819.2011.02218.x","article-title":"Screening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a cross-sectional study using baseline data","volume":"65","author":"Kusumi","year":"2011","journal-title":"Psychiatry Clin Neurosci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:04Z","timestamp":1620960124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201701200-00023"}},"subtitle":["A case series"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005900","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}